Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
J Physiol Pharmacol ; 72(1)2021 Feb.
Article in English | MEDLINE | ID: mdl-34272348

ABSTRACT

To explore the protective effects of L-carnitine on erectile function and reproductive function in rats with diabetes. A total of 60 male diabetes mellitus induced-erectile dysfunction (DMED) rats were randomly divided into three groups, 20 rats in each group. The blank group was fed normally, the control group was fed with 0.9% sodium chloride solution 5 ml/kg/day, and the experimental group was given L-carnitine 300 mg/kg/day. After six weeks, the Corpus cavernosum penis pressure (ICP) and mean arterial pressure (MAP) were measured. The sperm of epididymis were taken to detect the parameters of sperm. After six weeks of treatment, ICP and MAP in the experimental group were significantly higher than those in the control group and blank group (p < 0.05), and sperm density and PR in the experimental group were significantly higher than those in the control group and the blank group (p < 0.05). Superoxide dismutase (SOD) in the experimental group was significantly higher than that in the control group and blank group (p < 0.05). Malondialdehyde (MDA) in the experimental group was significantly lower than that in the control group and blank group (p < 0.05). The follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone in the experimental group were significantly higher than those in the control group and blank group (p < 0.05). We conclude that L-carnitine can significantly improve erectile function and reproductive function in rats with diabetes and it has great potential in the treatment of systemic organ damage in DMED rats.


Subject(s)
Carnitine/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Erectile Dysfunction/prevention & control , Spermatozoa/drug effects , Animals , Arterial Pressure/drug effects , Diabetes Mellitus, Experimental/complications , Erectile Dysfunction/etiology , Follicle Stimulating Hormone/metabolism , Luteinizing Hormone/metabolism , Male , Malondialdehyde/metabolism , Rats , Rats, Sprague-Dawley , Sperm Count , Spermatozoa/metabolism , Testosterone/metabolism
2.
Eur Rev Med Pharmacol Sci ; 23(24): 10588-10599, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31858581

ABSTRACT

OBJECTIVE: The innate lymphoid cells (ILCs) are a recently discovered type of innate immune cell. The functions of these cells resemble different T-cell subtypes. These cells play important roles in local injury, inflammation, pathogen infection, or tumours. However, there have been few studies focusing on the role of ILCs in nasal diseases. MATERIALS AND METHODS: We reviewed the literature about the roles of ILCs in nasal inflammation, tissue remodeling, and cancer. RESULTS: The ILCs represent a newly identified family of innate immune cells. These cells play important roles in inflammation, immune responses, tissue remodeling, and cancer immunity. The ILCs, especially ILC2s, play important roles in CRSwNP and AR. ILC2s may be involved in the pathogenesis of eosinophilic inflammation in non-allergic nasal diseases, such as non-allergic CRSwNP and non-allergic rhinitis. ILCs also play pro-tumor or anti-tumor roles in cancer immunity for head and neck cancer. CONCLUSIONS: LC2s may be a useful therapeutic target for CRSwNP and AR. ILCs may also represent new therapeutic targets to activate anti-tumor immunity in head and neck cancer.


Subject(s)
Head and Neck Neoplasms/pathology , Immunity, Innate , Lymphocytes/pathology , Nasal Mucosa/pathology , Airway Remodeling/immunology , Asthma/immunology , Asthma/pathology , Cytokines/immunology , Fibrosis , Head and Neck Neoplasms/immunology , Humans , Inflammation , Lymphocytes/immunology , Nasal Mucosa/immunology , Rhinitis/immunology , Rhinitis/pathology
3.
Int J Immunogenet ; 44(6): 337-342, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28929626

ABSTRACT

Hepatitis C virus (HCV) is a major cause of chronic hepatitis. Previous studies have identified a number of single nucleotide polymorphisms that are associated with HCV infection. Human platelet antigens (HPAs) polymorphisms play an important role in several diseases. Here, we demonstrated the association of the HPA-2, HPA-3, HPA-5 and HPA-15 polymorphisms with susceptibility to HCV infection in Chinese population. Overall, 118 patients with HCV and 167 controls were genotyped for HPAs. There were no significant differences in the allele and genotype frequency distribution for the HPA-3, HPA-5 and HPA-15 systems between the patients with chronic HCV infection and the healthy controls (p > .05). However, the genotype frequency of HPA-2aa was significantly lower, while HPA-2ab/bb was significantly higher in patients than that in the controls (p = .006). The allele frequency of HPA-2a in patients was significantly lower than that in the control group (p = .005). In contrast, HPA-2b in patients was significantly higher than that in the control group (p = .005). We conclude that HPA-2 polymorphism is associated with susceptibility to HCV infection, and individuals carrying the HPA-2b allele may have a higher risk of HCV infection compared with individuals carrying HPA-2a.


Subject(s)
Antigens, Human Platelet/genetics , Asian People/genetics , Genetic Predisposition to Disease , Hepacivirus/physiology , Hepatitis C, Chronic/genetics , Polymorphism, Single Nucleotide/genetics , Adult , Female , Gene Frequency/genetics , Genotyping Techniques , Humans , Male
4.
J Laryngol Otol ; 131(8): 707-713, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28683848

ABSTRACT

OBJECTIVE: To investigate the role of local allergic inflammation and Staphylococcus aureus enterotoxins in chronic rhinosinusitis with nasal polyps. METHODS: This study included 36 patients with chronic rhinosinusitis with nasal polyps and 18 controls. Total immunoglobulin E, eosinophil cationic protein, staphylococcal enterotoxin types A and B specific immunoglobulin E, staphylococcal enterotoxin types A and B, and myeloperoxidase levels were determined. RESULTS: Four patients with chronic rhinosinusitis with nasal polyps had a local allergy. All chronic rhinosinusitis with nasal polyps patients tested negative for staphylococcal enterotoxin types A and B specific immunoglobulin E. The chronic rhinosinusitis with nasal polyps group had significantly elevated staphylococcal enterotoxin types A and B levels in the supernatant. Fourteen patients belonged to the eosinophilic chronic rhinosinusitis with nasal polyps group and the others were characterised as having non-eosinophilic chronic rhinosinusitis with nasal polyps. CONCLUSION: Local allergy may play a role in chronic rhinosinusitis with nasal polyps, independent of staphylococcal enterotoxin superantigens. Staphylococcal enterotoxins may be important in the pathogenesis of chronic rhinosinusitis with nasal polyps; however, their roles as superantigens were not confirmed in this study. In Chinese subjects, chronic rhinosinusitis with nasal polyps usually manifests as a neutrophilic inflammation.


Subject(s)
Enterotoxins/blood , Hypersensitivity/immunology , Nasal Polyps/immunology , Rhinitis/immunology , Sinusitis/immunology , Staphylococcus aureus/immunology , Adult , Case-Control Studies , China , Chronic Disease , Enterotoxins/immunology , Eosinophil Cationic Protein/blood , Female , Humans , Hypersensitivity/blood , Hypersensitivity/microbiology , Immunoglobulin E/blood , Immunoglobulin E/immunology , Male , Middle Aged , Nasal Polyps/blood , Nasal Polyps/microbiology , Peroxidase/blood , Rhinitis/blood , Rhinitis/microbiology , Sinusitis/blood , Sinusitis/microbiology , Superantigens/blood , Superantigens/immunology
5.
HLA ; 89(5): 293-300, 2017 05.
Article in English | MEDLINE | ID: mdl-28296231

ABSTRACT

BACKGROUND: The human leukocyte antigen (HLA) system is the most polymorphic gene cluster in humans. High-resolution donor-recipient matching for HLA genes improves patient survival after unrelated hematopoietic stem cell transplantation. MATERIALS AND METHODS: In this study, we analyzed the high-resolution allele and haplotype frequencies at the HLA-A, -B and -DRB1 loci in the Liaoning Han population and analyzed its relationships with other populations. RESULTS: The 3 most frequent alleles at the HLA-A, -B and -DRB1 loci were A*24:02, A*02:01:01G, A*11:01; B*13:02, B*46:01, B*40:01:01G; DRB1*09:01, DRB1*15:01 and DRB1*07:01, respectively. The most frequent 2-locus haplotypes were A*30:01-B*13:02 and B*13:02-DRB1*07:01. A*30:01-B*13:02-DRB1*07:01 was determined to be the predominant 3-locus haplotype. Hot maps and multiple correspondence analyses based on the frequencies of HLA specificities, which allow statistical visualization of dependent and independent relationships among variables, indicate that the Liaoning Han population is closely related to Northern populations of China and shows relative close relationships with Asian populations. CONCLUSION: These data will provide an outline of the HLA characteristics of healthy individuals in our region and help bone marrow transplantation patients find suitable HLA-matched donors.


Subject(s)
Gene Frequency , HLA-A Antigens/genetics , HLA-B27 Antigen/genetics , HLA-DRB1 Chains/genetics , Polymorphism, Genetic , Tissue Donors , Alleles , Asian People , Bone Marrow Transplantation , China , Exons , Gene Expression , HLA-A Antigens/classification , HLA-A Antigens/immunology , HLA-B27 Antigen/classification , HLA-B27 Antigen/immunology , HLA-DRB1 Chains/classification , HLA-DRB1 Chains/immunology , Haplotypes , Histocompatibility Testing , Humans , Polymerase Chain Reaction , Sequence Analysis, DNA , White People
6.
Eur Rev Med Pharmacol Sci ; 20(24): 5067-5076, 2016 12.
Article in English | MEDLINE | ID: mdl-28051265

ABSTRACT

OBJECTIVE: Hypoxia-inducible factor (HIF) is considered an important transcription factor due to its roles in glycolysis, angiogenesis, cell differentiation, apoptosis, and other cellular pathways. It takes the role in various physiological and pathological states, such as solid tumors, vascular injury, and atherosclerotic lesion progression. In recent studies, HIF is found as a master regulator of body inflammation and immunity, not only in hypoxia but also in normoxia. Nasal inflammation has a close relationship with anoxia. But the role of HIF in nasal inflammation is still unclear. MATERIALS AND METHODS: We searched the Pubmed using the key words: "Hypoxia-inducible factor" and "nasal" or "Hypoxia-inducible factor", and reviewed the related articles. RESULTS: HIF is composed of HIF-α and HIF-ß subunits. HIF-a is an adjusting relational subunit, which is divided into three subtypes: HIF-1a, HIF-2a, and HIF-3a. HIF-1a is the key component and best understood. HIF-1a can be activated under hypoxic conditions or by various cytokines and growth factors. HIF-1α accumulation is critical for sustaining human allergic effector cell survival and function. The level of HIF-1a is increased in the patients with allergic rhinitis and become a new therapeutic target. HIF-1a also plays an important role in the pathogenesis of CRS and polyp formation. Some research found that the expression of HIF-1α was increased in CRS with polyps. CONCLUSIONS: HIF-1a takes an important role in allergic rhinitis and chronic sinusitis. It will be a key therapeutic target of these diseases in the future.


Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit/physiology , Rhinitis, Allergic/immunology , Cell Hypoxia , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Inflammation , Neovascularization, Pathologic , Sinusitis
7.
Genet Mol Res ; 13(1): 1540-7, 2014 Mar 12.
Article in English | MEDLINE | ID: mdl-24668628

ABSTRACT

We investigated the immune response effects of porcine circovirus type 2 (PCV2) on cells inoculated with pseudorabies attenuated vaccine (PRV). Real-time PCR was used to detect the mRNA expression levels of the regulatory cytokines IL-4, IL-10, IL-12p40, and IFN-γ in pig peripheral blood mononuclear cells, after in vitro single vaccination and co-inoculation with PCV2 and the PRV. We found that PRV causes upregulation of IL-4, IL-12p40, and IFN-γ mRNA expression, while PCV2 causes mRNA upregulation of IL-4, IL-10, and IL-12p40. Moreover, PCV2 inhibited PRV-induced upregulation of IL-4, IL-12p40, and IFN-γ mRNA expression; IFN-γ mRNA expression was significantly inhibited. We conclude that PCV2 can reduce the cellular immune response to PRV.


Subject(s)
Circovirus/genetics , Cytokines/immunology , RNA, Messenger/genetics , Vaccines/immunology , Animals , Circovirus/immunology , Circovirus/pathogenicity , Cytokines/genetics , Gene Expression Regulation/immunology , Humans , Leukocytes, Mononuclear , RNA, Messenger/immunology , Swine/virology , Vaccines/genetics
9.
J Int Med Res ; 40(3): 1192-206, 2012.
Article in English | MEDLINE | ID: mdl-22906294

ABSTRACT

Laryngeal mucosa-associated lymphoid tissue (MALT) lymphoma is rare, with only 25 cases reported in the literature. This report presents a case of laryngeal MALT lymphoma in a 35-year-old female with a 6-year history of progressively worsening hoarseness. MALT lymphoma was diagnosed based on biopsy and immunohistochemical analysis. The patient received two cycles of cyclophosphamide + epirubicin + vincristine + prednisone (CHOP) chemo therapy, which was ineffective. (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) showed (18)F-FDG accumulation in the larynx only and identified stage IE lymphoma. CHOP chemotherapy was terminated and the patient was treated with radiotherapy. After 3 months (total radiation dose 27 Gy), (18)F-FDG PET/CT scan showed that the laryngeal lesion was in complete remission. A review of the literature on the MEDLINE(®)/PubMed(®) databases regarding laryngeal MALT lymphoma and the use of PET/CT found that radiotherapy is the first-line treatment for stage I and II MALT lymphoma.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Fluorodeoxyglucose F18 , Laryngeal Neoplasms/diagnostic imaging , Lymphoma, B-Cell, Marginal Zone/diagnostic imaging , Adult , Biopsy , Combined Modality Therapy , Cyclophosphamide/therapeutic use , Doxorubicin/therapeutic use , Female , Humans , Immunohistochemistry , Laryngeal Neoplasms/drug therapy , Laryngeal Neoplasms/radiotherapy , Lymphoma, B-Cell, Marginal Zone/drug therapy , Lymphoma, B-Cell, Marginal Zone/radiotherapy , Prednisone/therapeutic use , Radionuclide Imaging , Treatment Outcome , Vincristine/therapeutic use
10.
J Int Med Res ; 39(1): 311-20, 2011.
Article in English | MEDLINE | ID: mdl-21672335

ABSTRACT

Inflammatory myofibroblastic tumour (IMT) and low-grade myofibroblastic sarcoma (LGMS) have similar morpho logical and immunophenotypic features, but LGMS is more malignant than IMT and the treatment requires a wider surgical margin plus post-operative chemotherapy or radiotherapy. To date, only 28 cases of IMT and two cases of LGMS have been reported in the laryngopharynx. Recent studies have suggested that anaplastic lymphoma kinase (ALK) and cytokeratin are important markers for differentiating between the two tumours. Here, two cases involving different myofibroblastic tumours of the larynx are reported. Based on the histological and immunohistochemical results, case 1 was diagnosed as IMT involving the right arytenoepiglottic fold, while case 2 was diagnosed as LGMS involving the epiglottic-glossal surface. There was no recurrence or metastasis in either case after post-operative follow-up (12 and 14 months, respectively). It is difficult to distinguish IMT from LGMS; both morphological and immunohistological analyses are required.


Subject(s)
Hypopharynx/pathology , Myofibroblasts/pathology , Myosarcoma/diagnosis , Myosarcoma/pathology , Otorhinolaryngologic Neoplasms/diagnosis , Otorhinolaryngologic Neoplasms/pathology , Adult , Anaplastic Lymphoma Kinase , Biomarkers, Tumor/analysis , Diagnosis, Differential , Female , Humans , Hypopharynx/surgery , Immunohistochemistry , Keratins/analysis , Middle Aged , Myosarcoma/surgery , Otorhinolaryngologic Neoplasms/surgery , Receptor Protein-Tyrosine Kinases/analysis
11.
J Int Med Res ; 38(6): 1885-92, 2010.
Article in English | MEDLINE | ID: mdl-21226991

ABSTRACT

Treatment options for laryngeal carcinoma, one of the most common head and neck malignancies, consist of radiotherapy, surgery, chemotherapy or a combination thereof. The functional treatment of laryngeal carcinoma poses a considerable challenge because of its resistance to chemotherapy and radiotherapy, and its tendency for local recurrence. Finding ways to inhibit the energy supply of malignant tumours is becoming an increasingly attractive proposition. Glucose transporter-1 (Glut-1; encoded by the SLC2A1 gene in humans) is the main transporter of glucose in solid carcinomas and has become a focus of cancer research. Recently, it was shown that the increased expression of SLC2A1 in head and neck carcinomas is correlated with lymph node metastasis, poor survival and clinical stage, and revealed that the suppression of SLC2A1 expression by antisense oligodeoxynucleotides decreased glucose uptake and inhibited the proliferation of Hep-2 cells. Thus, the authors propose the suppression of SLC2A1 expression as a new therapeutic target for laryngeal carcinoma.


Subject(s)
Glucose Transporter Type 1/antagonists & inhibitors , Glucose Transporter Type 1/metabolism , Laryngeal Neoplasms/therapy , Molecular Targeted Therapy , Glucose/analogs & derivatives , Glucose Transporter Type 1/biosynthesis , Glucose Transporter Type 1/genetics , Humans , RNA Interference , Signal Transduction
12.
J Int Med Res ; 38(6): 2040-6, 2010.
Article in English | MEDLINE | ID: mdl-21227008

ABSTRACT

This study examined levels of hypoxia inducible factor-1α (HIF-1α) protein in 40 laryngeal squamous cell carcinoma specimens using immunohistochemistry. Correlations between HIF-1α immunoreactivity and patient age, tumour lymph node metastasis stage, histological grade (extent of differentiation), and alcohol and smoking history were evaluated. Of the tumour tissues obtained, 35 (87.5%) were located in the glottic area and five (12.5%) in the supraglottic area. All patients were male and aged between 35 and 71 years; 12 (30.0%) presented with lymph node metastases, 24 (60.0%) had cancer classified as T(1) or T(2), and 16 (40.0%) as high clinical stage (T(3) or T(4)). The pattern of HIF-1α protein localization in tumour tissues, when present, was mixed nuclear/cytoplasmic, with positive HIF-1α expression in 27 patients (67.5%). Differences in HIF-1α levels in samples from different tumour stages and in those with lymph node-positive versus lymph node-negative cancers were statistically significant.


Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Laryngeal Neoplasms/metabolism , Adult , Aged , Humans , Immunohistochemistry , Laryngeal Neoplasms/pathology , Male , Middle Aged
13.
J Int Med Res ; 38(6): 2160-8, 2010.
Article in English | MEDLINE | ID: mdl-21227022

ABSTRACT

This report presents a case of nasopharyngeal diffuse large B-cell lymphoma and a literature review concerning the use of [(18)F]fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). A 37-year old man was admitted to hospital complaining of nasal secretions with minor epistaxis and a 20-year history of snoring. Nasal endoscopy found diffuse swelling in the nasopharynx and a biopsy was performed. Prior to chemotherapy, FDG-PET/CT showed soft tissue diffuse thickening and FDG accumulation in the nasopharynx and bilateral cervical lymph nodes; FDG did not accumulate elsewhere. After four cycles of chemotherapy (rituximab, cyclo phosphamide, doxorubicin, vincristine) and prednisone treatment, FDG-PET/CT showed that FDG still accumulated in the nasopharynx and bilateral cervical lymph nodes, therefore radiotherapy was initiated. At 1 year, FDG-PET/CT showed no FDG accumulation. Immunohistochemical analysis revealed that the tumour was positive for phosphorylated protein kinase B (Akt), suggesting that FDG uptake may be associated with factors activated by the phosphatidylinositol 3-kinase/Akt signalling pathway.


Subject(s)
Fluorodeoxyglucose F18/pharmacokinetics , Glucose Transporter Type 1/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Lymphoma, Large B-Cell, Diffuse/enzymology , Nasopharyngeal Neoplasms/enzymology , Phosphatidylinositol 3-Kinase/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Adult , Humans , Immunohistochemistry , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Nasopharyngeal Neoplasms/diagnostic imaging , Nasopharyngeal Neoplasms/pathology , Nasopharynx/pathology , Positron-Emission Tomography , Tomography, X-Ray Computed
14.
J Int Med Res ; 38(6): 2169-77, 2010.
Article in English | MEDLINE | ID: mdl-21227023

ABSTRACT

Nasal glomus tumours are extremely rare neoplasms with poorly understood histogenesis, but which are clinically recognized as benign. The neoplastic cells of glomus tumours resemble normal glomus cells and are arranged around a varying number of thin-walled, sometimes branching, capillaries. CD34 is known to be a marker of tumour progenitor cells. In this report, two cases of benign nasal glomus tumour are presented. The tumours were excised completely via endoscopic endonasal surgery under local anaesthesia. During surgery, there was little bleeding and the post-surgical course for both patients was uneventful. Tumour cells from both cases were positive for α-smooth muscle actin, actin, vimentin and CD34 protein. Thus, CD34 positivity against a background of other immunohisto chemical markers is helpful in the differential diagnosis of glomus tumours.


Subject(s)
Antigens, CD34/metabolism , Glomus Tumor/metabolism , Nose Neoplasms/metabolism , Adolescent , Adult , Glomus Tumor/diagnostic imaging , Glomus Tumor/pathology , Humans , Immunohistochemistry , Male , Nose Neoplasms/diagnostic imaging , Nose Neoplasms/pathology , Staining and Labeling , Tomography, X-Ray Computed
15.
J Int Med Res ; 37(6): 2000-8, 2009.
Article in English | MEDLINE | ID: mdl-20146901

ABSTRACT

Inflammatory myofibroblastic tumours (IMT) of the nasal cavity and nasal sinus are rare and, although over 50 cases have been reported in the English-language literature, their precise aetiology and biological behaviour have not been elucidated. Recent studies suggest that anaplastic lymphoma kinase (ALK)-positive tumours have a very low risk of metastasis, but ALK reactivity does not appear to correlate with recurrence. Between March 2002 and December 2008, we encountered three cases of maxillary sinus IMT and investigated them to determine the clinicopathological course, prognosis and immunohistochemical expression of ALK. Two of the patients died < 13 months after the initial diagnosis and the third had multiple recurrences. All three cases were immunohisto chemically negative for ALK expression. IMT of the sino-nasal tract is rare and may undergo malignant transformation in a minority of cases. The three cases manifested progressive extension with bone destruction and multiple recurrences, and two cases had a fatal outcome and one case had high recurrence.


Subject(s)
Inflammation/complications , Inflammation/enzymology , Maxillary Sinus Neoplasms/diagnosis , Maxillary Sinus Neoplasms/enzymology , Myofibroma/diagnosis , Myofibroma/enzymology , Protein-Tyrosine Kinases/metabolism , Adult , Anaplastic Lymphoma Kinase , Female , Humans , Immunohistochemistry , Inflammation/pathology , Maxillary Sinus Neoplasms/complications , Maxillary Sinus Neoplasms/pathology , Middle Aged , Myofibroma/complications , Myofibroma/pathology , Prognosis , Receptor Protein-Tyrosine Kinases
16.
Cytotherapy ; 10(5): 469-78, 2008.
Article in English | MEDLINE | ID: mdl-18608353

ABSTRACT

BACKGROUND: Mesenchymal stem cells (MSC) have recently been shown to possess immunomodulatory properties in vitro and in vivo. The present study aimed to investigate the regulatory effect of MSC transplantation on the immuno-inflammatory response in myocardial infarction (MI). METHODS: MI was induced in Sprague-Dawley rats by left anterior descending coronary artery ligation, and the animals were randomly assigned into the following three groups: sham ( n=8); phosphate-buffered saline (PBS) injected (MI+PBS, n=8); and MSC transplantation (MI+MSC, n=8). BrdU-labeled MSC or PBS was transplanted into peri-infarct myocardium by direct myocardial injection. At 1 and 28 days post-transplantation, cardiac function was evaluated by echocardiography. Transplanted cells were investigated through immunohistochemistry. Lymphocyte cytotoxic activity was evaluated with the crystal violet method. The activity of NF-kappaB and protein expression of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6 and IL-10 in myocardium were assessed by immunohistochemistry and Western blot. RESULTS: Echocardiographic examination revealed that the MSC transplantation prevented left ventricular dilation and dysfunction at 28 days after the operation. BrdU-stained cells were found living in host heart 4 weeks after transplantation. MSC transplantation attenuated the cytotoxic activity of spleen lymphocytes. Transplantation of MSC inhibited the activity of NF-kappaB, attenuated the protein production of TNF-alpha and IL-6, and increased the expression of IL-10 in peri-infarct myocardium. DISCUSSION: MSC transplantation modulated the immuno-inflammatory response in MI. The immuno-inflammatory regulatory effect of MSC transplantation might partly account for the cardiac protection in myocardial infarction.


Subject(s)
Cardiomyopathy, Dilated/immunology , Interleukin-10/metabolism , Mesenchymal Stem Cell Transplantation , Myocardial Infarction/therapy , Animals , Cardiomyopathy, Dilated/prevention & control , Cytotoxicity, Immunologic/immunology , Echocardiography , Immunohistochemistry , Interleukin-10/genetics , Interleukin-6/genetics , Interleukin-6/metabolism , Lymphocytes/immunology , Male , Myocardial Infarction/immunology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , NF-kappaB-Inducing Kinase
SELECTION OF CITATIONS
SEARCH DETAIL
...